Multimodality breast cancer screening in women with a familial or genetic predisposition

Por Trop, I., Lalonde, L., Mayrand, M.H., David, J., Larouche, N., Provencher, D.
Publicado em 2010

Pharmacotherapeutic management of chronic noncancer pain in primary care: lessons for pharmacists

Por Jouini G, Choinière M, Martin E, Perreault S, Berbiche D, Lussier D, Hudon E, Lalonde L
Publicado em 2014-03-01

Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention

Por Perreault, S, Blais, L, Lamarre, D, Dragomir, A, Berbiche, D, Lalonde, L, Laurier, C, St-Maurice, F, Collin, J
Publicado em 2005

Breast magnetic resonance imaging: are those who need it getting it?

Por Tan, S., David, J., Lalonde, L., El Khoury, M., Labelle, M., Younan, R., Patocskai, E., Richard, J., Trop, I.
Publicado no Curr Oncol (2017)

Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies

Por Gagnon, J., Lévesque, E., Borduas, F., Chiquette, J., Diorio, C., Duchesne, N., Dumais, M., Eloy, L., Foulkes, W., Gervais, N., Lalonde, L., L’Espérance, B., Meterissian, S., Provencher, L., Richard, J., Savard, C., Trop, I., Wong, N., Knoppers, B.M., Simard, J.
Publicado no Curr Oncol (2016)